Bharat Biotech

Cannot Recommend A COVID-19 Vaccine Without Making Sure It Is Safe And Effective, Says WHO On Covaxin Approval

The World Health Organisation on Monday said it was expecting additional information from India’s Bharat Biotech regarding its coronavirus vaccine Covaxin and also declared that it “cannot cut corners” before…

View Post

Govt Allows Serum Institute To Enrol 7-11 Year Olds In Covid-19 Vaccine Trial

Indian drug regulator on Tuesday allowed the vaccine manufacturer Serum Institute of India to enrolL children between seven and 11 years of age for its COVID-19 vaccine trial, as per…

View Post

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

The Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age has been completed by Bharat Biotech and is expected to submit the data…

View Post

Govt Approves Bharat Biotech’s Ankleshwar Plant To Produce Covaxin: Mandaviya

Union minister Mansukh Mandaviya said the government has given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin on Tuesday. “Govt of India approves vaccine manufacturing facility…

View Post

Brazil Scraps Covaxin’s Emergency-Use Application After Bharat Biotech Terminates Pact With Partners

Brazil has now scrapped the Emergency Use Authorisation request made by the Indian company for the vaccine, this step has been taken after suspending the proposed clinical trials of Bharat…

View Post

Brazil Suspends Clinical Trials Of Covaxin After Termination Of Agreement

The clinical studies of Bharat Biotech’s COVID-19 vaccine, Covaxin has been suspended by Brazil, following termination of the company’s agreement with its partner there said the South American Country’s health…

View Post

Bharat Biotech’s Partner Ocugen Seeks Approval For Covaxin In Canada

The US company said in a regulatory filing that Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the…

View Post

Menu

Bharat Biotech

Cannot Recommend A COVID-19 Vaccine Without Making Sure It Is Safe And Effective, Says WHO On Covaxin Approval

Govt Allows Serum Institute To Enrol 7-11 Year Olds In Covid-19 Vaccine Trial

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

Govt Approves Bharat Biotech’s Ankleshwar Plant To Produce Covaxin: Mandaviya

Brazil Scraps Covaxin’s Emergency-Use Application After Bharat Biotech Terminates Pact With Partners

Brazil Suspends Clinical Trials Of Covaxin After Termination Of Agreement

Bharat Biotech’s Partner Ocugen Seeks Approval For Covaxin In Canada

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report